1458019

Neomycyna B

United States Pharmacopeia (USP) Reference Standard

• Synonim(y): (2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-b-L-idopyranosyl)-b-D-ribofuranosyl]-D-streptamine sulfate)
• Wzór empiryczny (zapis Hilla): C₂₃H₄₆N₆O₁₃ · xH₂SO₄
• Numer CAS: 28002-70-2
• Masa cząsteczkowa: 614.64 (free base basis)
• MDL number: MFCD00037007
• UNSPSC Code: 41116107
• NACRES: NA.24
• eCl@ss: 25140904

Właściwości

• grade: pharmaceutical primary standard
• agency: USP
• API family: neomycin
• form: solid
• packaging: pkg of 150 mg
• manufacturer/tradename: USP
• application(s): USP Biologics; pharmaceutical
• format: neat
• storage temp.: −20°C
• SMILES string: [S](=O)(=O)(O)O.N[C@H]1[C@H](O[C@H]([C@H]([C@@H]1O)O)CN)O[C@@H]2[C@H](O[C@H]([C@@H]2O)O[C@H]3[C@@H]([C@H](C[C@H]([C@@H]3O)N)N)O[C@H]4O[C@@H]([C@H]([C@@H]([C@H]4N)O)O)CN)CO
• InChI: 1S/C23H46N6O13.H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;/m1./s1
• InChI key: OIXVKQDWLFHVGR-WQDIDPJDSA-N

Opis

General description

Neomycin B is one of the major components of neomycin sulfate, an aminoglycoside antibiotic produced by Streptomyces fradiae. It exerts bactericidal effects by binding to the 30S ribosomal subunit, leading to inhibition of protein synthesis and misreading of mRNA. The USP standard supports identification and quantification of this individual neomycin component in complex mixtures.The USP biologics antibiotics category includes a wide range of antimicrobial agents that are essential in treating bacterial infections. These antibiotics are derived from various natural sources or synthesized to combat specific pathogens effectively. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of antibiotic therapeutics throughout their lifecycle.The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.
Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Wzorzec referencyjny Neomycin B USP, przeznaczony do stosowania w określonych testach jakości i oznaczeniach, jak określono w kompendiach USP. Również do użytku z monografią USP, taką jak siarczan neomycyny

Analysis Note

Produkty te są przeznaczone wyłącznie do testów i oznaczeń. Nie są one przeznaczone do podawania ludziom lub zwierzętom i nie mogą być stosowane do diagnozowania, leczenia lub wyleczenia jakichkolwiek chorób.

Other Notes

Ten produkt jest częścią programu USP Biologics.

Karty charakterystyki wydane przez USP można znaleźć tutaj.

Sales restrictions may apply.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS07
• Słowo ostrzegawcze: Warning
• Kody zagrożeń: H317
• Ostrzeżenia: P261 - P272 - P280 - P302 + P352 - P333 + P313 - P362 + P364
• Hazard Classifications: Skin Sens. 1
• Klasa składowania: 13 - Non Combustible Solids
• WGK: WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable